These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12611116)

  • 1. Renal manifestations of hepatitis C virus infection. Extrahepatic complications often are silent--and thus overlooked.
    Bandi L
    Postgrad Med; 2003 Feb; 113(2):73-6, 86. PubMed ID: 12611116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis.
    Garini G; Allegri L; Carnevali L; Catellani W; Manganelli P; Buzio C
    Am J Kidney Dis; 2001 Dec; 38(6):E35. PubMed ID: 11728995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral therapy of symptomatic HCV-mixed cryoglobulinemia after liver transplant: case report and literature review.
    Francesca Donato M; Banfi G; Cresseri D; Battista Fogazzi G; Martin P; Messa P; Fabrizi F
    Int J Artif Organs; 2013 May; 36(5):367-72. PubMed ID: 23446762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of IFN treatment for extrahepatic manifestations].
    Matsumori A
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):569-73. PubMed ID: 15359863
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies.
    Garini G; Allegri L; Vaglio A; Buzio C
    Ann Ital Med Int; 2005; 20(2):71-80. PubMed ID: 16052839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hepatitis C-virus-related glomerulonephritis.
    Kamar N; Rostaing L; Alric L
    Kidney Int; 2006 Feb; 69(3):436-9. PubMed ID: 16514428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy with interferon-alpha plus ribavirin for membranoproliferative glomerulonephritis induced by hepatitis C virus.
    Lopes EP; Valente LM; Silva AE; Kirsztajn GM; Cruz CN; Ferraz ML
    Braz J Infect Dis; 2003 Oct; 7(5):353-7. PubMed ID: 14552746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Difficulties in treatment of kidney diseases related to HCV infection].
    Jabłońska J; Kozłowska J
    Przegl Epidemiol; 2009; 63(1):75-8. PubMed ID: 19522231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature.
    Ahmed MS; Wong CF; Shawki H; Kapoor N; Pandya BK
    Clin Nephrol; 2008 Apr; 69(4):298-301. PubMed ID: 18397706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to high-dose interferon-alpha after failure of standard therapy in MPGN associated with hepatitis C virus infection.
    Sarac E; Bastacky S; Johnson JP
    Am J Kidney Dis; 1997 Jul; 30(1):113-5. PubMed ID: 9214409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus associated glomerulopathies.
    Ozkok A; Yildiz A
    World J Gastroenterol; 2014 Jun; 20(24):7544-54. PubMed ID: 24976695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal manifestations of hepatitis C infection.
    Daghestani L; Pomeroy C
    Am J Med; 1999 Mar; 106(3):347-54. PubMed ID: 10190385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of HCV-associated cryoglobulinaemic glomerulonephritis with a combination of interferon-alpha and ribavirin.
    Misiani R; Bellavita P; Baio P; Caldara R; Ferruzzi S; Rossi P; Tengattini F
    Nephrol Dial Transplant; 1999 Jun; 14(6):1558-60. PubMed ID: 10383026
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN.
    Alric L; Plaisier E; Thébault S; Péron JM; Rostaing L; Pourrat J; Ronco P; Piette JC; Cacoub P
    Am J Kidney Dis; 2004 Apr; 43(4):617-23. PubMed ID: 15042538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of HCV-related cryoglobulinemic glomerulonephritis with double-filtration plasmapheresis and interferon combination therapy.
    Namba T; Shiba R; Yamamoto T; Hirai Y; Moriwaki T; Matsuda J; Kadoya H; Takeji M; Yamada Y; Yoshihara H; Yamauchi A
    Clin Exp Nephrol; 2010 Aug; 14(4):372-6. PubMed ID: 20467773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report.
    Shimada M; Nakamura N; Endo T; Yamabe H; Nakamura M; Murakami R; Narita I; Tomita H
    BMC Nephrol; 2017 Mar; 18(1):109. PubMed ID: 28356063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C and renal disease: epidemiology, diagnosis, pathogenesis and therapy.
    Morales JM; Kamar N; Rostaing L
    Contrib Nephrol; 2012; 176():10-23. PubMed ID: 22310777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive therapies.
    Garini G; Allegri L; Lannuzzella F; Vaglio A; Buzio C
    Acta Biomed; 2007; 78(1):51-9. PubMed ID: 17687818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon.
    Mazzaro C; Zorat F; Comar C; Nascimben F; Bianchini D; Baracetti S; Donada C; Donadon V; Pozzato G
    J Rheumatol; 2003 Aug; 30(8):1775-81. PubMed ID: 12913934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.
    Saadoun D; Resche-Rigon M; Thibault V; Piette JC; Cacoub P
    Arthritis Rheum; 2006 Nov; 54(11):3696-706. PubMed ID: 17075881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.